Loading...
Loading...
Among the 1 tracked institutional investors we monitor, GLMD (GALMED PHARMACEUTICALS LTD) is held with a combined value of $5.50K across 11,382 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $5.50K (0.00% of their portfolio). 1 fund reduced its position.
Total Institutional Value
$5.50K
Total Shares Held
11,382
Institutional Holders
1
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $5.50K | 0.00% | -70.2% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of GLMD with a position worth $5.50K, representing 0.00% of their portfolio. In total, 1 institutional investors hold GLMD with a combined value of $5.50K.
Institutional investors hold $5.50K worth of GLMD stock across 1 positions. The largest institutional holder is CITADEL ADVISORS LLC with $5.50K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For GLMD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their GLMD positions.